20 results
6-K
EX-99.1
PRTG
Portage Biotech Inc
29 Nov 22
Current report (foreign)
4:58pm
, the Company entered into an agreement with Oxford Sciences Innovation, Plc (“OSI”), the holder of $0.15 million notes plus accrued interest under … for 23,772 ordinary shares of iOx at a price of £162. Simultaneously, the Company entered into an agreement with Oxford Sciences Innovation, Plc (“OSI
6-K
EX-99.1
PRTG
Portage Biotech Inc
29 Aug 22
Current report (foreign)
4:00pm
Innovation, Plc (“OSI”), the holder of $0.15 million notes plus accrued interest under which OSI exchanged the notes plus accrued interest for 820 … with Oxford Sciences Innovation, Plc (“OSI”), the holder of $0.15 million notes plus accrued interest under which OSI exchanged the notes plus accrued
6-K
EX-2.1
PRTG
Portage Biotech Inc
19 Jul 22
Portage Biotech Acquires Outstanding Minority Interest of Invariant Natural Killer T cell (iNKT) Agonist Platform
9:01am
entered into by The Chancellor, Masters and Scholars of the University of Oxford, ISIS Innovation Limited, Ludwig Institute for Cancer Research Limited
6-K
EX-99.1
0q3rzyu9c7o
25 Feb 22
Current report (foreign)
5:29pm
6-K
EX-99.1
g4u242u77xm6x
23 Nov 21
Current report (foreign)
4:30pm
6-K
EX-99.1
1rkxas33z1u30l
28 May 20
Report of Foreign Private Issuer
12:19pm
6-K
EX-99.2
q1duum0htvfdh3
3 Mar 20
Consolidated Interim Financial Statements
12:00am
6-K
EX-99.2
ge717
31 Dec 19
Consolidated Interim Financial Statements
10:03am
6-K
EX-99.2
nih2h4z0t
31 Dec 19
Consolidated Interim Financial Statements
10:03am
6-K
EX-99.1
2xwlk8 stav9ioc6si2
19 Feb 19
Report of Foreign Private Issuer
10:37am
6-K
hnu64wz0cof6wkeyj
14 Aug 18
Report of Foreign Issuer
4:36pm
6-K
gnnyi9ps0gb 32br
27 Feb 03
Nine Months Ended December 31, 2002
12:00am
- Prev
- 1
- Next